These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 37759071)

  • 21. Primary and additional treatment preference in aggressive retinopathy of prematurity and type 1 retinopathy of prematurity.
    Jang JH; Kang YK; Park HS; Kim K; Kim SS; Han JY; Kim HW; Bang JW; Song JS; Park SJ; Woo SJ; Joo KS; Yoo WS; Chung I; Cho YW; Lee JH; Choi HJ; Chung YR
    BMJ Open Ophthalmol; 2023 Jan; 8(1):. PubMed ID: 37278416
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparison of Vitamin D Levels in Premature Infants with and without Retinopathy of Prematurity.
    Boskabadi H; Abrishami M; Shoeibi N; Sanei Z; Moradi A; Zakerihamidi M
    Arch Iran Med; 2022 Apr; 25(4):209-213. PubMed ID: 35942992
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The association of various obstetric and perinatal factors with retinopathy of prematurity.
    Ozgur Gursoy O; Gurer HG; Yildiz Eren C; Erdogan Ozgur P; Gursoy H
    Int Ophthalmol; 2022 Sep; 42(9):2719-2728. PubMed ID: 35352291
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The association between systemic vascular endothelial growth factor and retinopathy of prematurity in premature infants: a systematic review.
    Kandasamy Y; Hartley L; Rudd D; Smith R
    Br J Ophthalmol; 2017 Jan; 101(1):21-24. PubMed ID: 27388246
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Pulmonary Hypertension in Preterm Infants Treated With Laser vs Anti-Vascular Endothelial Growth Factor Therapy for Retinopathy of Prematurity.
    Nitkin CR; Bamat NA; Lagatta J; DeMauro SB; Lee HC; Patel RM; King B; Slaughter JL; Campbell JP; Richardson T; Lewis T
    JAMA Ophthalmol; 2022 Nov; 140(11):1085-1094. PubMed ID: 36201183
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The clinical role of vascular endothelial growth factor (VEGF) system in the pathogenesis of retinopathy of prematurity.
    Kwinta P; Bik-Multanowski M; Mitkowska Z; Tomasik T; Pietrzyk JJ
    Graefes Arch Clin Exp Ophthalmol; 2008 Oct; 246(10):1467-75. PubMed ID: 18546007
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The German ROP Registry: data from 90 infants treated for retinopathy of prematurity.
    Walz JM; Bemme S; Pielen A; Aisenbrey S; Breuß H; Alex AF; Wagenfeld L; Schiedel S; Krohne TU; Stahl A;
    Acta Ophthalmol; 2016 Dec; 94(8):e744-e752. PubMed ID: 27197876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Apelin in epiretinal fibrovascular membranes of patients with retinopathy of prematurity and the changes after intravitreal bevacizumab.
    Zhang Y; Jiang YR; Lu Q; Yin H; Tao Y
    Retina; 2013 Mar; 33(3):613-20. PubMed ID: 23296045
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Vascular endothelial growth factor and insulin-like growth factor-1 in preterm infants with retinopathy of prematurity.
    Peirovifar A; Gharehbaghi MM; Gharabaghi PM; Sadeghi K
    Singapore Med J; 2013 Dec; 54(12):709-12. PubMed ID: 24356758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Circulating stem cell populations in preterm infants: implications for the development of retinopathy of prematurity.
    Machalinska A; Modrzejewska M; Kotowski M; Dziedziejko V; Kucia M; Kawa M; Safranow K; Baskiewicz-Masiuk M; Modrzejewska A; Karczewicz D; Rudnicki J; Machalinski B
    Arch Ophthalmol; 2010 Oct; 128(10):1311-9. PubMed ID: 20938001
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Association of retinal vascular endothelial growth factor with avascular retina in a rat model of retinopathy of prematurity.
    Budd SJ; Thompson H; Hartnett ME
    Arch Ophthalmol; 2010 Aug; 128(8):1014-21. PubMed ID: 20697002
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Retinopathy of Prematurity: Therapeutic Strategies Based on Pathophysiology.
    Cayabyab R; Ramanathan R
    Neonatology; 2016; 109(4):369-76. PubMed ID: 27251645
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Genetic polymorphisms of vascular endothelial growth factor and angiopoietin 2 in retinopathy of prematurity.
    Bányász I; Bokodi G; Vannay A; Szebeni B; Treszl A; Vásárhelyi B; Tulassay T; Szabó A
    Curr Eye Res; 2006; 31(7-8):685-90. PubMed ID: 16877277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Risk factors for recurrence after intravitreal anti-vascular endothelial growth factor injection for retinopathy of prematurity].
    Hao QF; Chen J; Ruan P; Li GP; Zhang J; Chen HM; Guo HX; Sun XJ; Cheng XY
    Zhongguo Dang Dai Er Ke Za Zhi; 2022 Nov; 24(11):1207-1212. PubMed ID: 36398545
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Vascular endothelial growth factor and hepatocyte growth factor levels are differentially elevated in patients with advanced retinopathy of prematurity.
    Lashkari K; Hirose T; Yazdany J; McMeel JW; Kazlauskas A; Rahimi N
    Am J Pathol; 2000 Apr; 156(4):1337-44. PubMed ID: 10751359
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Expression of Total Vascular Endothelial Growth Factor and the Anti-angiogenic VEGF 165 b Isoform in the Vitreous of Patients with Retinopathy of Prematurity.
    Zhao M; Xie WK; Bai YJ; Huang LZ; Wang B; Liang JH; Yin H; Li XX; Shi X
    Chin Med J (Engl); 2015 Sep; 128(18):2505-9. PubMed ID: 26365970
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Serum levels of vascular endothelial growth factor and related factors after intravitreous bevacizumab injection for retinopathy of prematurity.
    Wu WC; Lien R; Liao PJ; Wang NK; Chen YP; Chao AN; Chen KJ; Chen TL; Hwang YS; Lai CC
    JAMA Ophthalmol; 2015 Apr; 133(4):391-7. PubMed ID: 25569026
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Retinopathy of Prematurity among Very-Low-Birth-Weight Infants in Korea: Incidence, Treatment, and Risk Factors.
    Hwang JH; Lee EH; Kim EA
    J Korean Med Sci; 2015 Oct; 30 Suppl 1(Suppl 1):S88-94. PubMed ID: 26566363
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Inflammatory and Angiogenic Mediators in Amniotic Fluid Are Associated With the Development of Retinopathy of Prematurity in Preterm Infants.
    Woo SJ; Park JY; Hong S; Kim YM; Park YH; Lee YE; Park KH
    Invest Ophthalmol Vis Sci; 2020 May; 61(5):42. PubMed ID: 32446247
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aqueous cytokine levels associated with severity of type 1 retinopathy of prematurity and treatment response to ranibizumab.
    Lyu J; Zhang Q; Jin H; Xu Y; Chen C; Ji X; Zhang X; Rao Y; Zhao P
    Graefes Arch Clin Exp Ophthalmol; 2018 Aug; 256(8):1469-1477. PubMed ID: 29948178
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.